We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+0.94%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.9B
AUM Growth
-$1.92B
(-2.7%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
792
New
60
Increased
302
Reduced
281
Closed
78
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$761M |
| 2 |
PPG Industries
PPG
|
+$342M |
| 3 |
Pultegroup
PHM
|
+$278M |
| 4 |
Apple
AAPL
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$701M |
| 2 |
Medtronic
MDT
|
+$355M |
| 3 |
Lockheed Martin
LMT
|
+$309M |
| 4 |
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$286M |
| 5 |
Western Digital
WDC
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.4% |
| 2 | Technology | 13.5% |
| 3 | Healthcare | 12.95% |
| 4 | Industrials | 11.68% |
| 5 | Energy | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Chunghwa Telecom
CHT
$37B
| $297K | ﹤0.01% |
8,800
| – | – |
2013 Q3
10 quarters
|
|
702
Stryker
SYK
$112B
| $294K | ﹤0.01% |
2,740
| – | – |
2014 Q1
8 quarters
|
|
703
Telkom Indonesia
TLK
$12.6B
| $286K | ﹤0.01% |
11,268
| – | – |
2013 Q3
10 quarters
|
|
704
PennyMac Financial
PFSI
$3.18B
| $282K | ﹤0.01% |
+23,984
| New | +$289K |
2016 Q1
0 quarters
|
|
|
CVO
705
DELISTED
Cenevo, Inc.
CVO
| $280K | ﹤0.01% |
83,295
| – | – |
2014 Q4
5 quarters
|
|
706
MidCap Financial Investment
MFIC
$700M
| $271K | ﹤0.01% |
16,290
-501,760
| -97% | -$7.75M |
2013 Q2
11 quarters
|
|
707
Newmont
NEM
$122B
| $269K | ﹤0.01% |
10,112
-69
| -0.7% | -$1.6K |
2015 Q3
2 quarters
|
|
708
SK Telecom
SKM
$12.6B
| $251K | ﹤0.01% |
7,534
+42
| +0.6% | +$1.36K |
2013 Q3
10 quarters
|
|
709
CACI
CACI
$13.5B
| $247K | ﹤0.01% |
2,319
+160
| +7% | +$15K |
2015 Q4
1 quarter
|
|
710
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $187K | ﹤0.01% |
+663
| New | +$250K |
2016 Q1
0 quarters
|
|
|
PSG
711
DELISTED
Performance Sports Group Ltd.
PSG
| $146K | ﹤0.01% |
45,900
-120,088
| -72% | -$771K |
2015 Q4
1 quarter
|
|
712
Comstock
LODE
$144M
| $93K | ﹤0.01% |
+1,000
| New | +$117K |
2016 Q1
0 quarters
|
|
713
ICICI Bank
IBN
$106B
| $82K | ﹤0.01% |
+12,660
| New | +$74.2K |
2016 Q1
0 quarters
|
|
714
CEMIG Preferred Shares
CIG
$6.55B
| $50K | ﹤0.01% |
43,297
-41,659
| -49% | -$34K |
2013 Q2
11 quarters
|
|
715
AH Realty Trust
AHRT
$445M
| – | – |
-104,380
| Closed | -$1.09M | – |
|
716
Abercrombie & Fitch
ANF
$6.45B
| – | – |
-1,260,725
| Closed | -$34M | – |
|
717
Buckle
BKE
$2.4B
| – | – |
-50,189
| Closed | -$1.54M | – |
|
718
Brady Corp
BRC
$3.94B
| – | – |
-43,615
| Closed | -$1M | – |
|
719
Carlisle Companies
CSL
$13.3B
| – | – |
-6,014
| Closed | -$533K | – |
|
720
Quest Diagnostics
DGX
$26.4B
| – | – |
-2,630,191
| Closed | -$187M | – |
|
721
Eastman Chemical
EMN
$7.3B
| – | – |
-43,352
| Closed | -$2.93M | – |
|
722
Fastenal
FAST
$57.8B
| – | – |
-310,400
| Closed | -$3.17M | – |
|
723
Del Monte Corp
DMC
$1.41B
| – | – |
-21,489
| Closed | -$835K | – |
|
724
Greif Class B
GEF.B
$4.18B
| – | – |
-46,351
| Closed | -$1.98M | – |
|
725
Global Payments
GPN
$22.3B
| – | – |
-589,381
| Closed | -$38M | – |
|
Similar funds
Boston Partners's Q1 2016 Portfolio in Review
As of Q1 2016, Boston Partners held 792 positions worth $67.9B, down 2.7% from $69.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2016 filing shows 60 new, 302 increased, 281 reduced and 78 closed positions. Its largest new stake was Pultegroup: 16,274,531 shares worth $304M. The largest sale was Pfizer, an estimated $701M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- Boston Partners's largest Q1 2016 buy was Pultegroup: 16,274,531 shares worth $304M.
- Boston Partners added most to Bank of America in Q1 2016, an estimated $761M increase.
- Boston Partners's biggest Q1 2016 reduction was Pfizer, cutting an estimated $701M.
- Boston Partners fully exited TOWERS WATSON & CO COM STK CL A (DE) in Q1 2016, selling an estimated $286M.
- Boston Partners's ten largest holdings make up 17% of its $67.9B portfolio in Q1 2016.
- Boston Partners opened 60 new positions and closed 78 in Q1 2016.
- Boston Partners's portfolio value fell 2.7% quarter-over-quarter to $67.9B.
Based on Boston Partners's 13F filing for Q1 2016, filed 12 May 2016.